Neuropharmacology

Biography

Dr. Ming Chen got his Ph.D. from the State University of New York and had postdoc training at the Harvard University. During research career, he has focused on the unique roles of Ca2+ signaling and Ca2+-dependent enzymes in understanding of the formation of plaques and tangles in aging and sporadic Alzheimer’s disease (sAD). Based on the research findings and a critical and comprehensive analysis of current issues, Dr. Chen has proposed that sAD should be understood from an aging perspective, rather than as a “discrete disease”, and that “energy and Ca2+ signaling deficits” be the rational drug targets for intervention. He also suggests that a group of “risk factors”, rather than “pathogenic” factors, plays the primary roles in the onset of sAD.

Research Interest

Alzheimer’s disease